GENE ONLINE|News &
Opinion
Blog

Astellas Pharma
Partnerships JapanJoint Venture Partner Group
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Interviews BioJapanJapan
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Sept 4-Sept 8
2023-09-12
Asia-Pacific Lawsuit
Astellas Withdraws Lawsuit Against IRA but Maintains Concerns
2023-09-11
Licensing Astellas PharmaGene Therapy
Astellas Secures Licensing Agreement with 4D Molecular Therapeutics for Gene Therapy Vector Technology
2023-07-12
Trials & Approvals Astellas PharmaFezolinetant
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
M&A Astellas Pharma
Astellas Trains Sights On Iveric Bio In $5.9 Billion Acquisition
2023-05-03
Trials & Approvals Xtandi
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Trials & Approvals Phase 3 Trial
Astellas Clears Primary Endpoints In Prostate Cancer And Menopause Trials
2023-03-14
Special JPM
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
Trials & Approvals Astellas Pharma
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
Trials & Approvals Astellas Pharma
Astellas’ Claudin 18.2 Antibody Shows Its Teeth In GEJ Cancer Trial
2022-11-17
Asia-Pacific Astellas Pharma
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Trials & Approvals Astellas Pharma
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
1 2 3
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top